From: Nonspecific interstitial pneumonia: clinical associations and outcomes
 | SAD-NSIP group | i-NSIP-Ab + group | i-NSIP-Ab-group | p |
---|---|---|---|---|
ABG | Â | Â | Â | Â |
PaO2 (mmHg), initial presentation | 74.1 ± 8.9 | 74.2 ± 10.8 | 74.2 ± 10.8 | 0.648 |
  After follow up | 73.0 ± 10.7 | 73.2 ± 11.8 | 73.9 ± 10.6 | 0.934 |
PaCO2(mmHg), initial presentation | 36.8 ± 4.9 | 35.3 ± 4.2 | 35.7 ± 4.5 | 0.478 |
  After follow up | 37.1 ± 4.9 | 35.4 ± 4.2 | 35.2 ± 4.1 | 0.206 |
PFT | Â | Â | Â | Â |
 FVC (%), initial presentation | 70.1 ± 16.3 | 72.3 ± 13.5 | 74.5 ± 12.3 | 0.789 |
  After follow up | 68.9 ± 14.9 | 74.1 ± 14.7 | 75.7 ± 14.4 | 0.664 |
 TLC (%), initial presentation | 75.1 ± 12.4 | 74.1 ± 13.2 | 73.4 ± 12.1 | 0.912 |
  After follow up | 73.4 ± 11.7 | 74.4 ± 14.9 | 76.0 ± 17.6 | 0.847 |
 DLCO (%), initial presentation | 55.1 ± 10.9 | 53.4 ± 16.2 | 52.1 ± 15.2 | 0.198 |
  After follow up | 51.4 ± 11.0 | 54.2 ± 18.0 | 56.8 ± 16.6 | 0.173 |
BALF | Â | Â | Â | Â |
 M (%), initial presentation | 42.9 ± 21.7 | 43.8 ± 22.6 | 45.6 ± 23.7 | 0.397 |
  After follow up | 46.9 ± 24.7 | 44.0 ± 21.7 | 43.6 ± 24.3 | 0.425 |
 L (%), initial presentation | 39.2 ± 20.9 | 38.9 ± 22.4 | 41.3 ± 23.5 | 0.876 |
  After follow up | 37.1 ± 22.8 | 38.4 ± 20.7 | 44.8 ± 25.0 | 0.776 |
 N (%), initial presentation | 10.1 ± 18.2 | 13.6 ± 14.2 | 12.1 ± 11.9 | 0.671 |
  After follow up | 11.9 ± 19.6 | 13.2 ± 15.7 | 10.5 ± 13.1 | 0.807 |
 E (%), initial presentation | 5.0 ± 8.8 | 5.2 ± 6.0 | 4.1 ± 5.0 | 0.801 |
  After follow up | 5.3 ± 8.2 | 4.8 ± 5.7 | 3.9 ± 4.6 | 0.752 |
 CD4/CD8, initial presentation | 1.5 ± 1.9 | 1.3 ± 1.3 | 1.2 ± 0.9 | 0.813 |
  After follow up | 1.2 ± 1.8 | 1.2 ± 1.1 | 1.4 ± 1.5 | 0.947 |